Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2003
12/11/2003US20030229226 Cathepsin cysteine protease inhibitors
12/11/2003US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders
12/11/2003US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229204 PCG-1, a novel brown fat PPARgamma coactivator
12/11/2003US20030229200 Useful in treating or preventing obesity
12/11/2003US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers
12/11/2003US20030229130 Imidazolinylmethyl aralkylsulfonamides
12/11/2003US20030229124 Lipid peroxide-lowering compositions
12/11/2003US20030229116 Enamine derivatives
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229091 Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
12/11/2003US20030229088 Novel methods and compositions for alleviating pain
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
12/11/2003US20030229034 Drug delivery; nucleic acids; complexing
12/11/2003US20030229025 Antidiabetic agents, eating disorders, dietetics
12/11/2003US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
12/11/2003US20030228394 Novel chromium (III) alpha amino acid complexes
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228362 Controlled release lipoic acid
12/11/2003US20030228348 Health food and preparation having an anti-obesity effect
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2487905A1 Use of cgmp - stimulating compounds
12/11/2003CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2486933A1 Tetrahydropyran derivative
12/11/2003CA2486424A1 Oil-soluble pigment compositions
12/11/2003CA2486409A1 Policosanol compositions, extraction from novel sources, and uses thereof
12/11/2003CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003CA2485194A1 Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
12/11/2003CA2485111A1 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2482345A1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369432A2 Soluble highly branched glucose polymers and process for their preparation
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1369123A1 A health-care product comprising lotus rhizome and process for its preparation
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1368648A2 Detection of compounds that modulate inflammatory responses
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368365A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
12/10/2003EP1368358A1 Isoxazoline derivatives as anti-depressants
12/10/2003EP1368349A1 Xanthine derivative, production and use thereof as a medicament
12/10/2003EP1368348A1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists
12/10/2003EP1368332A1 A lactonization process
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368063A2 Complex of modafinil and cyclodextrin
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368046A1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
12/10/2003EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368025A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
12/10/2003EP1368017A2 Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
12/10/2003EP1368013A1 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1148874B1 Use of anticonvulsant derivatives for treating bulimia nervosa
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0893995B1 Anticachectic composition
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003EP0674714B1 Recombinant canine gastric lipase and pharmaceutical compositions
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction
12/10/2003CN1461215A A personal condition management system
12/10/2003CN1461210A Preparation of vitamin emulsions and concentrates thereof
12/10/2003CN1460667A Pineapplie leaf extract, its preparation method and application
12/10/2003CN1460518A Composite enriched nutrient tablet
12/10/2003CN1460512A Water-soluble propolis liquor and its preparation method
12/10/2003CN1460480A Hypoglycemic health-care food for diabetes type Ôàí"
12/10/2003CN1460472A Biquanide vanadium complex plaster preparation for curing diabetes and its application
1 ... 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 ... 1298